SecBot SecBot
Insider Cluster ·Filed Mar 27, 2026

SLNO

SOLENO THERAPEUTICS INC
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago
Insider cluster: 2 insiders, $274K total
Actionable Insight • Neutral

Monitor for follow-up filings or disclosures that may explain the rationale behind these sales; given the small size relative to market cap, this cluster is likely routine and not a strong signal.

DirectionNeutral
Confidencelow
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$30.05
T+0 close · Mar 26, 2026 · via day close
Latest settled
+75.54%
T+20 · $52.75
Vs SPY
+62.80%
α at T+20
Next horizon
T+60
due 5mo ago
  1. T+0 · Mar 27 $30.05entry
  2. T+1 · 8mo ago +1.30%α +1.66% · $30.44
  3. T+5 · 8mo ago +73.88%α +70.01% · $52.25
  4. T+20 · 7mo ago +75.54%α +62.80% · $52.75
  5. T+60 · due 5mo ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Analysis based on filing metadata only, document content was unavailable. Two insiders at Soleno Therapeutics Inc. (SLNO) conducted open-market sales totaling approximately $274K within the last 7 days, representing a small fraction of the company's $1.6B market cap.

Key Financial Metrics

Direction
selling

Key Facts

  • Filing is an insider trading cluster involving two executives at SLNO.
  • Chief Commercial Officer and Senior VP of Clinical Development each sold shares in late March 2026.
  • Total open-market sales amount to ~$274K, or 0.017% of SLNO's $1.6B market cap.
  • No document content available to assess context or motivation behind trades.

Financial Impact

$274K in open-market sales, or 0.017% of market cap

insider ownershipmarket sentiment

Risk Factors

  • Potential perception of insider lack of confidence, though magnitude is too small to be material
  • Lack of filing content limits ability to assess whether sales are part of a pre-arranged plan or reactive to material non-public information

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

Report based on filing metadata.

Track record

10 reports on SLNO

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +2.57% at T+1 after the Feb 26, 2026 report. 2 of 4 went positive at some point.

Filters
  1. Jun 11, 202622w ago Institutional Cluster Bullish 6/10 No price data
  2. Jun 11, 202622w ago Institutional Cluster Mixed 4/10 No price data
  3. May 28, 202624w ago 15-12G Bearish 8/10 No price data
  4. May 28, 202624w ago EFFECT Bearish 5/10 No price data
  5. May 18, 202626w ago 8-K / 25-NSE Bullish 8/10 Entry $53.01 No price data
  6. Apr 7, 202631w ago 8-K Bearish 7/10 Entry $52.35 to $52.62 ▼ −0.52% +4.81% vs SPY
  7. Apr 6, 202632w ago 8-K Bullish 8/10 Entry $52.25 to $52.64 ▲ +0.75% −3.39% vs SPY
  8. Mar 27, 202633w ago Insider Cluster Neutral 3/10 Viewing Entry $30.05 to $52.25 ▲ +73.88% +70.01% vs SPY
  9. Feb 26, 202637w ago 8-K Bullish 8/10 Entry $38.09 to $38.57 ▲ +1.26% +2.42% vs SPY
  10. Feb 26, 202637w ago 8-K Neutral 3/10 Entry $38.09 to $38.57 ▲ +1.26% +2.39% vs SPY
Showing 10 of 10

US Market Status

Market Closed · Opens in 8h 12m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 31, 2026